{
    "2021-08-10": [
        [
            {
                "time": "2023-10-18",
                "original_text": "天坛生物注射用重组人凝血因子Ⅶa正式开展一期临床试验",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "注射用重组人凝血因子Ⅶa",
                        "一期临床试验"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "天坛生物：“注射用重组人凝血因子VIIa”已通过伦理审查、完成临床入组前准备等工作",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "注射用重组人凝血因子VIIa",
                        "伦理审查",
                        "临床入组前准备"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "天坛生物(600161.SH)：“注射用重组人凝血因子VIIa”已通过伦理审查、完成临床入组前准备等工作",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "600161.SH",
                        "注射用重组人凝血因子VIIa",
                        "伦理审查",
                        "临床入组前准备"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}